What women on estrogen therapy need to understand about real uterine safety
Progesterone is one of the most misunderstood hormones in women’s health.
One of the most common—and potentially risky—misconceptions is this:
“If I’m using progesterone cream, I’m protected.”
Clinically, that is often not the case.
If you are using estrogen therapy and still have a uterus, the form of progesterone you use matters—not just for symptom relief, but for endometrial protection and long-term safety.
Why Progesterone Matters in Hormone Therapy
Estrogen stimulates the endometrial lining.
Without adequate progesterone to counterbalance that effect, the lining can continue to thicken over time, increasing the risk of endometrial hyperplasia and, in some cases, cancer.
This protective effect is not optional—it is a core requirement of safe hormone therapy in women with an intact uterus.
And importantly, this protection depends on achieving sufficient progesterone levels at the tissue level, not simply using a product labeled “progesterone.”
The Problem With Transdermal Progesterone
Progesterone creams are widely used because they are accessible, marketed as natural, and often perceived as safer.
However, the key clinical question is not whether progesterone is present in the product.
It is whether enough progesterone reaches the bloodstream and the endometrium to provide protection.
Research consistently shows that transdermal progesterone:
- Produces low and inconsistent serum levels
- Has highly variable absorption between individuals
- Does not reliably achieve adequate endometrial exposure
Patients may still notice improvements in sleep or mood, but these effects are neurologic—not evidence of uterine protection. Feeling better does not necessarily mean you are protected.
Even clinical guidance provided in women’s health settings reflects this clearly:
Progesterone cream does not produce meaningful systemic levels and does not provide endometrial protection
What Actually Provides Reliable Endometrial Protection
For patients using estrogen therapy, we rely on delivery methods that consistently achieve therapeutic levels.
Oral micronized progesterone remains one of the most commonly used and well-studied option, with predictable absorption and documented protective effects on the endometrium.
For patients who cannot tolerate oral progesterone, vaginal or rectal administration of micronized progesterone can be used. These routes allow for effective absorption and, in the case of vaginal delivery, more direct exposure to the uterus.
Another important option is the levonorgestrel-releasing intrauterine device (IUD), such as Mirena. This provides localized endometrial protection and is often used in combination with systemic estrogen therapy.
In some cases, synthetic progestins are used. These have been extensively studied and are effective for endometrial protection, though they differ from bioidentical progesterone in structure and side effect profile.
The common thread across all of these options is simple:
They achieve sufficient progesterone activity at the level of the endometrium.
Why the Misconception Persists
Progesterone cream remains popular for a few key reasons.
It is often marketed as a natural or bioidentical option, which can create a sense of safety. Some patients also experience subjective improvements in sleep or calmness, reinforcing the belief that it is working systemically.
There is also a widespread assumption that anything absorbed through the skin must be effective.
But progesterone does not behave the same way as other hormones transdermally. Absorption is inconsistent, and more importantly, insufficient for uterine protection.
The Real Risk: A False Sense of Security
The concern with progesterone cream is not that it has no effect.
It’s that it can create the impression that estrogen is being safely balanced—when it may not be.
Over time, unopposed estrogen stimulation of the endometrium can lead to complications that are often silent until they are not.
This is why the form and dosing of progesterone is not a minor detail—it is a safety decision.
Our Clinical Approach at Vital Moon Wellness
Hormone therapy should be both effective and medically sound.
At Vital Moon Wellness, we take a structured approach to ensure that progesterone therapy is not only improving symptoms, but also providing appropriate protection.
This includes selecting delivery methods that achieve therapeutic levels, individualizing treatment based on patient response, and adjusting care as needed over time.
Because the goal is not just symptom relief—
It is long-term health, safety, and function.
Your Next Step
If you are using estrogen therapy—or considering it—and are unsure whether your current progesterone approach is providing adequate protection, it’s worth taking a closer look.
We can help you evaluate your current plan and determine the most appropriate, evidence-based strategy for your body.
Schedule your consultation here: vitalmoonwellness.com
References:
Hormone Therapy for Postmenopausal Women (Review)
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004143.pub5/full
Treatment of Symptoms of the Menopause: Endocrine Society Clinical Practice Guideline
https://academic.oup.com/jcem/article/100/11/3975/2836060
Wren BG, McFarland K, Edwards L. “Transdermal progesterone and the endometrium.”
https://pubmed.ncbi.nlm.nih.gov/11910616/
Disclaimer: All content and information on this website is for informational and educational purposes only, does not constitute medical advice, and does not establish any kind of patient-client relationship by your use of this website. Although we strive to provide accurate general information, the information presented here is not a substitute for any kind of professional advice, and you should not rely solely on this information. Always consult a professional in the area for your particular needs and circumstances prior to making any professional, legal, medical and financial decisions.
